DekaBank Deutsche Girozentrale’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-150,000
| Closed | -$331K | – | 1485 |
|
|
2023
Q2 | $331K | Sell |
150,000
-100,000
| -40% | -$221K | ﹤0.01% | 1098 |
|
|
2023
Q1 | $734K | Hold |
250,000
| – | – | ﹤0.01% | 939 |
|
|
2022
Q4 | $565K | Hold |
250,000
| – | – | ﹤0.01% | 1008 |
|
|
2022
Q3 | $485K | Hold |
250,000
| – | – | ﹤0.01% | 1052 |
|
|
2022
Q2 | $654K | Hold |
250,000
| – | – | ﹤0.01% | 975 |
|
|
2022
Q1 | $745K | Hold |
250,000
| – | – | ﹤0.01% | 970 |
|
|
2021
Q4 | $916K | Hold |
250,000
| – | – | ﹤0.01% | 950 |
|
|
2021
Q3 | $1.06M | Hold |
250,000
| – | – | ﹤0.01% | 890 |
|
|
2021
Q2 | $765K | Hold |
250,000
| – | – | ﹤0.01% | 973 |
|
|
2021
Q1 | $766K | Hold |
250,000
| – | – | ﹤0.01% | 953 |
|
|
2020
Q4 | $892K | Hold |
250,000
| – | – | ﹤0.01% | 895 |
|
|
2020
Q3 | $766K | Buy |
+250,000
| New | +$766K | ﹤0.01% | 836 |
|
|
2019
Q3 | – | Sell |
-57,000
| Closed | -$129K | – | 989 |
|
|
2019
Q2 | $129K | Buy |
57,000
+22,500
| +65% | +$50.9K | ﹤0.01% | 1059 |
|
|
2019
Q1 | $311K | Buy |
34,500
+6,000
| +21% | +$54.1K | ﹤0.01% | 989 |
|
|
2018
Q4 | $105K | Sell |
28,500
-6,000
| -17% | -$22.1K | ﹤0.01% | 1054 |
|
|
2018
Q3 | $311K | Hold |
34,500
| – | – | ﹤0.01% | 1011 |
|
|
2018
Q2 | $254K | Hold |
34,500
| – | – | ﹤0.01% | 1013 |
|
|
2018
Q1 | $174K | Buy |
+34,500
| New | +$174K | ﹤0.01% | 1007 |
|